Advertisement
Financial Highlights for the Three Months Ended September 30, 2007Compared to the Three Months Ended September 30, 2006:
Financial Highlights for the Nine Months Ended September 30, 2007 Comparedto the Nine Months Ended September 30, 2006:
Advertisement
Leonard Osser, Chairman and CEO of Milestone, noted, "I am pleased withthe progress we are making on preparing to accelerate the worldwide launch ofthe STA System. Moreover, our ongoing negotiations with various third partyplayers in the medical/healthcare arena have also been proving productive inidentifying compelling product development opportunities for our patentedCompuFlo(R) technology. As a consequence, we believe Milestone will end 2007ideally poised to achieve a number of ambitious growth objectives in thecoming year.
The Company will host a teleconference Monday, November 19, 2007,beginning at 11:00 AM Eastern Time, and invites all interested parties to joinmanagement in a discussion regarding the Company's financial performance,corporate progression and other meaningful developments. The conference callcan be accessed by dialing toll-free 1-800-218-0204. For those unable toparticipate at that time, a replay of the teleconference can be accesseddomestically by dialing 1-800-405-2236 and enter the passcode 11102398#. Thereplay will be available for 90 days.
About Milestone Scientific, Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engagedin pioneering proprietary, highly innovative technological solutions for themedical and dental markets. Central to the Company's IP platform and productdevelopment strategy is its patented CompuFlo(R) technology for the improvedand painless delivery of local anesthetic. Specifically, CompuFlo is acomputer-controlled, pressure sensitive infusion, perfusion, suffusion andaspiration technology, which provides real-time readouts of pressures, fluiddensities and flow rates, enabling the advanced delivery and removal of a widearray of fluids. The Single Tooth Anesthesia (STA(TM)) computer-controlledlocal anesthesia delivery system which uses this technology provides dentistswith audible and visual signals as to in-tissue pressure. Milestone'sexisting painless injection systems are currently sold in 25 countries. Formore information on these and other innovative Milestone products, pleasevisit the Company's web site found at http://www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding thetiming and financial impact of the Milestone's ability to implement itsbusiness plan, expected revenues and future success. These statements involvea number of risks and uncertainties and are based on assumptions involvingjudgments with respect to future economic, competitive and market conditionsand future business decisions, all of which are difficult or impossible topredict accurately and many of which are beyond Milestone's control. Some ofthe important factors that could cause actual results to differ materiallyfrom those indicated by the forward-looking statements are general economicconditions, failure to achieve expected revenue growth, changes in ouroperating expenses, adverse patent rulings, FDA or legal developments,competitive pressures, changes in customer and market requirements andstandards, and the risk factors detailed from time to time in Milestone'speriodic filings with the Securities and Exchange Commission, includingwithout limitation, Milestone's Annual Report on Form 10-KSB for the yearended December 31, 2006. The forward looking-statements in this press releaseare based upon management's reasonable belief as of the date hereof. Mil
